Get the Stockscreener App
3.4514
8.36%
-0.3186
Rocket Pharmaceuticals Inc stock is traded at $3.4514, with a volume of 2.03M.
It is down -8.36% in the last 24 hours and up +9.68% over the past month.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
See More
Previous Close:
$3.77
Open:
$3.72
24h Volume:
2.03M
Relative Volume:
0.57
Market Cap:
$371.73M
Revenue:
-
Net Income/Loss:
$-258.08M
P/E Ratio:
-1.2551
EPS:
-2.75
Net Cash Flow:
$-202.32M
1W Performance:
-12.31%
1M Performance:
+9.68%
6M Performance:
-56.87%
1Y Performance:
-79.65%
1-Day Range:
$3.42
$3.85
1-Week Range:
$3.42
$4.03
52-Week Range:
$2.19
$18.17
Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile
Name
Rocket Pharmaceuticals Inc
Sector
Industry
Phone
646-440-9100
Address
350 FIFTH AVENUE, NEW YORK, NY
Compare RCKT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RCKT
Rocket Pharmaceuticals Inc
|
3.445 | 406.80M | 0 | -258.08M | -202.32M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.08 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
641.99 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.26 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.85 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.78 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-20-25 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-25-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-30-25 | Downgrade | Evercore ISI | Outperform → In-line |
| May-28-25 | Downgrade | Goldman | Neutral → Sell |
| May-28-25 | Downgrade | JP Morgan | Overweight → Neutral |
| May-28-25 | Downgrade | Jefferies | Buy → Hold |
| May-28-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| May-28-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-27-25 | Downgrade | Needham | Buy → Hold |
| May-27-25 | Downgrade | TD Cowen | Buy → Hold |
| Mar-12-25 | Initiated | BMO Capital Markets | Outperform |
| Dec-30-24 | Initiated | Wedbush | Outperform |
| Dec-18-24 | Initiated | Jefferies | Buy |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Apr-02-24 | Initiated | Goldman | Neutral |
| Oct-24-23 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-01-23 | Initiated | Morgan Stanley | Overweight |
| Nov-08-22 | Initiated | Canaccord Genuity | Buy |
| Nov-01-22 | Initiated | BTIG Research | Buy |
| Jul-08-22 | Initiated | Raymond James | Outperform |
| Oct-20-21 | Resumed | Cowen | Outperform |
| Mar-02-21 | Initiated | Stifel | Buy |
| Feb-18-21 | Initiated | Needham | Buy |
| Dec-16-20 | Initiated | UBS | Buy |
| Dec-08-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-02-20 | Initiated | JP Morgan | Overweight |
| Jun-25-20 | Resumed | BofA/Merrill | Buy |
| Jun-01-20 | Resumed | Oppenheimer | Outperform |
| Nov-06-19 | Initiated | Chardan Capital Markets | Buy |
| Sep-26-19 | Initiated | Piper Jaffray | Overweight |
| Apr-23-19 | Initiated | Robert W. Baird | Outperform |
| Mar-15-19 | Initiated | BofA/Merrill | Buy |
| Feb-05-19 | Initiated | Oppenheimer | Outperform |
| Sep-13-18 | Initiated | Ladenburg Thalmann | Buy |
| Jul-10-18 | Initiated | William Blair | Outperform |
View All
Rocket Pharmaceuticals Inc Stock (RCKT) Latest News
Published on: 2025-11-03 08:59:54 - newser.com
How Rocket Pharmaceuticals Inc. Equity Warrant stock benefits from tech adoption2025 Pullback Review & Daily Stock Trend Reports - newser.com
Can Rocket Pharmaceuticals Inc. stock deliver strong Q4 earningsMarket Activity Recap & Verified Swing Trading Watchlists - newser.com
Is it time to cut losses on Rocket Pharmaceuticals Inc. Equity WarrantMarket Growth Summary & Weekly Breakout Watchlists - newser.com
Rocket Pharmaceuticals Inc. stock chart pattern explainedOil Prices & Long-Term Growth Stock Strategies - newser.com
Is Rocket Pharmaceuticals Inc. stock entering bullish territoryJuly 2025 Fed Impact & Real-Time Chart Pattern Alerts - newser.com
Using R and stats models for Rocket Pharmaceuticals Inc. forecasting2025 Market Outlook & Community Supported Trade Ideas - newser.com
Using data models to predict Rocket Pharmaceuticals Inc. Equity Warrant stock movement2025 Winners & Losers & Growth Focused Stock Pick Reports - newser.com
Long term hold vs stop loss in Rocket Pharmaceuticals Inc.2025 Support & Resistance & Short-Term High Return Ideas - newser.com
Will Rocket Pharmaceuticals Inc. Equity Warrant stock benefit from upcoming earnings reports2025 Momentum Check & Weekly Return Optimization Alerts - newser.com
How to integrate Rocket Pharmaceuticals Inc. Equity Warrant into portfolio analysis tools2025 Investor Takeaways & Smart Money Movement Tracker - newser.com
Will Rocket Pharmaceuticals Inc. (9IP1) stock see insider accumulationJuly 2025 Decliners & Short-Term Trading Opportunity Alerts - newser.com
Is Rocket Pharmaceuticals Inc. (9IP1) stock good for wealth creationMarket Trend Report & Safe Capital Growth Tips - newser.com
Applying big data sentiment scoring on Rocket Pharmaceuticals Inc. Equity Warrant2025 Volatility Report & Free Weekly Watchlist of Top Performers - newser.com
How Rocket Pharmaceuticals Inc. (9IP1) stock trades pre earningsMarket Activity Recap & Verified Entry Point Signals - newser.com
What dividend safety score for Rocket Pharmaceuticals Inc. stockPortfolio Value Summary & Daily Volume Surge Signals - newser.com
Is Rocket Pharmaceuticals Inc. Equity Warrant stock a safe haven assetWeekly Stock Recap & AI Powered Trade Plan Recommendations - newser.com
Published on: 2025-11-03 01:22:42 - newser.com
Sentiment analysis tools applied to Rocket Pharmaceuticals Inc.Trade Exit Report & Free AI Powered Buy and Sell Recommendations - newser.com
How Rocket Pharmaceuticals Inc. Equity Warrant stock reacts to inflationary pressures2025 Fundamental Recap & Weekly Momentum Stock Picks - newser.com
Is Rocket Pharmaceuticals Inc. Equity Warrant stock poised for growthJuly 2025 Patterns & Weekly Top Gainers Trade List - newser.com
Rocket Pharmaceuticals Inc. Equity Warrant recovery potential after sell offQuarterly Portfolio Review & Fast Gaining Stock Reports - newser.com
How Rocket Pharmaceuticals Inc. Equity Warrant stock compares to industry benchmarksWeekly Gains Report & Low Risk Entry Point Tips - newser.com
What technical models suggest about Rocket Pharmaceuticals Inc.’s comeback2025 Fundamental Recap & Weekly Momentum Stock Picks - newser.com
Applying big data sentiment scoring on Rocket Pharmaceuticals Inc.2025 Macro Impact & Technical Confirmation Alerts - newser.com
Will a bounce in Rocket Pharmaceuticals Inc. offer an exitWeekly Gains Summary & Fast Exit and Entry Trade Guides - newser.com
Why Rocket Pharmaceuticals Inc. stock is in analyst buy zoneJuly 2025 Pullbacks & Weekly Top Gainers Alerts - newser.com
How to use Fibonacci retracement on Rocket Pharmaceuticals Inc.Trade Risk Assessment & Daily Volume Surge Signals - newser.com
Is Rocket Pharmaceuticals Inc. (9IP1) stock undervalued historicallyJuly 2025 Update & Accurate Technical Buy Alerts - newser.com
Why Rocket Pharmaceuticals Inc. (9IP1) stock attracts wealthy investors2025 Technical Patterns & Precise Buy Zone Identification - newser.com
Published on: 2025-11-02 06:26:40 - newser.com
Will Rocket Pharmaceuticals Inc. Equity Warrant see short term momentumWeekly Trade Recap & Daily Profit Maximizing Tips - newser.com
Rocket Pharmaceuticals Inc. recovery potential after sell off2025 Technical Patterns & Safe Capital Growth Trade Ideas - newser.com
Order flow analysis tools used on Rocket Pharmaceuticals Inc. Equity WarrantPortfolio Risk Summary & Reliable Entry Point Trade Alerts - newser.com
Detecting support and resistance levels for Rocket Pharmaceuticals Inc.2025 Market Sentiment & Weekly Stock Breakout Alerts - newser.com
Rocket Pharmaceuticals Inc Stock (RCKT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):